We are live on
!
Find out more
Aristotle Capital Management Portfolio holdings
AUM
$47.8B
1-Year Est. Return
13.38%
This Fund
S&P 500
This Quarter
Est. Return
+8.71%
1 Year Est. Return
+13.38%
3 Year Est. Return
+48.4%
5 Year Est. Return
+59.36%
10 Year Est. Return
+297.67%
AUM
$59B
AUM Growth
+$6.17B
(+12%)
Cap. Flow
+$2.29B
Cap. Flow
% of AUM
3.88%
Top 10 Holdings %
Top 10 Hldgs %
31.71%
Holding
182
New
7
Increased
119
Reduced
29
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Constellation Brands
STZ
|
+$853M |
| 2 |
Oshkosh
OSK
|
+$422M |
| 3 |
Lowe's Companies
LOW
|
+$116M |
| 4 |
Adobe
ADBE
|
+$79.3M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$71.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Novartis
NVS
|
+$628M |
| 2 |
East-West Bancorp
EWBC
|
+$305M |
| 3 |
Penske Automotive Group
PAG
|
+$14.2M |
| 4 |
JPMorgan Chase
JPM
|
+$1.21M |
| 5 |
iShares Global Healthcare ETF
IXJ
|
+$896K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.78% |
| 2 | Financials | 16.84% |
| 3 | Healthcare | 12.46% |
| 4 | Industrials | 12.23% |
| 5 | Materials | 9.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
PepsiCo
PEP
$190B
| $5.73M | 0.01% |
32,978
-1,631
| -5% | -$266K |
|
|
77
JPMorgan Chase
JPM
$950B
| $5.63M | 0.01% |
35,566
-7,398
| -17% | -$1.21M |
|
78
Cintas
CTAS
$81.5B
| $5.48M | 0.01% |
49,468
| – | – |
|
79
VF Corp
VFC
$5.99B
| $4.9M | 0.01% |
66,906
-4,328
| -6% | -$316K |
|
80
Pfizer
PFE
$145B
| $3.96M | 0.01% |
67,114
-1,086
| -2% | -$53.8K |
|
81
Church & Dwight Co
CHD
$24.4B
| $3.83M | 0.01% |
37,316
| – | – |
|
82
Royal Bank of Canada
RY
$290B
| $3.55M | 0.01% |
33,470
| – | – |
|
83
Illinois Tool Works
ITW
$84.9B
| $2.75M | ﹤0.01% |
11,129
+113
| +1% | +$26.3K |
|
84
Franklin Electric
FELE
$4.86B
| $2.46M | ﹤0.01% |
26,034
| – | – |
|
85
American Express
AXP
$234B
| $2.16M | ﹤0.01% |
13,196
-57
| -0.4% | -$9.72K |
|
86
Colgate-Palmolive
CL
$73.8B
| $1.94M | ﹤0.01% |
22,700
-2,106
| -8% | -$164K |
|
87
ExxonMobil
XOM
$638B
| $1.9M | ﹤0.01% |
31,017
-3,011
| -9% | -$188K |
|
88
J.M. Smucker
SJM
$12.7B
| $1.81M | ﹤0.01% |
13,317
| – | – |
|
89
Berkshire Hathaway Class A
BRK.A
$1.11T
| $1.8M | ﹤0.01% |
4
-1
| -20% | -$432K |
|
90
3M
MMM
$93.6B
| $1.7M | ﹤0.01% |
11,425
-6
| -0.1% | -$894 |
|
91
Allegion
ALLE
$14.1B
| $1.7M | ﹤0.01% |
12,806
-4,561
| -26% | -$597K |
|
92
Vanguard FTSE Developed Markets ETF
VEA
$234B
| $1.69M | ﹤0.01% |
33,037
+26,870
| +436% | +$1.38M |
|
93
Apple
AAPL
$4.52T
| $1.68M | ﹤0.01% |
9,477
+1,477
| +18% | +$233K |
|
94
Vanguard Morningstar Value ETF
VTV
$191B
| $1.68M | ﹤0.01% |
+11,443
| New | +$1.63M |
|
95
Kimberly-Clark
KMB
$37B
| $1.47M | ﹤0.01% |
10,290
| – | – |
|
|
PXD
96
DELISTED
Pioneer Natural Resource Co.
PXD
| $1.31M | ﹤0.01% |
7,184
-1,045
| -13% | -$192K |
|
97
Emerson Electric
EMR
$89B
| $1.26M | ﹤0.01% |
13,600
| – | – |
|
98
Union Pacific
UNP
$176B
| $1.25M | ﹤0.01% |
4,952
-35
| -0.7% | -$8.29K |
|
99
W.W. Grainger
GWW
$61.4B
| $976K | ﹤0.01% |
1,883
| – | – |
|
100
US Bancorp
USB
$100B
| $730K | ﹤0.01% |
13,000
| – | – |
|
Similar funds
TI
RIM
Aristotle Capital Management's Q4 2021 Portfolio in Review
As of Q4 2021, Aristotle Capital Management held 182 positions worth $59B, up 12% from $52.9B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Aristotle Capital Management deployed $2.29B of net new capital in Q4 2021, opening 7 new positions and adding to 119 existing holdings. Its largest new stake was Constellation Brands: 3,741,145 shares worth $939M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Novartis, an estimated $628M trimmed.
- Aristotle Capital Management's largest Q4 2021 buy was Constellation Brands: 3,741,145 shares worth $939M.
- Aristotle Capital Management added most to Oshkosh in Q4 2021, an estimated $422M increase.
- Aristotle Capital Management's biggest Q4 2021 reduction was Novartis, cutting an estimated $628M.
- Aristotle Capital Management fully exited Penske Automotive Group in Q4 2021, selling an estimated $14.2M.
- Aristotle Capital Management's ten largest holdings make up 32% of its $59B portfolio in Q4 2021.
- Aristotle Capital Management opened 7 new positions and closed 5 in Q4 2021.
- Aristotle Capital Management's portfolio value rose 12% quarter-over-quarter to $59B.
Based on Aristotle Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.